Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

Panacea Biotec announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as senior vice president- pharma research and pharma regulatory affairs, according to a regulatory filing.

New Delhi: As part of its organisational restructuring programme, drug firm Panacea Biotec on Tuesday said it has appointed Susheel Umesh as the Chief Executive of domestic formulations.

The company also announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as senior vice president- pharma research and pharma regulatory affairs, according to a regulatory filing.

Umesh brings in 27 years of experience, deep understanding of pharmaceutical industry, the company said.

Mangalum has 35 years of pharmaceutical manufacturing experience; out of which, he spent 25 years in Panacea Biotec.

Read Also: Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

Singla comes with 24 years of pharmaceutical research experience out of which he has spent 12 years in Panacea Biotec.

Panacea Biotec is a leading pharmaceutical and biotechnology company with established research, manufacturing and marketing capabilities.

Read Also: Panacea Biotec Bail out: Piramal, Bain offer Rs 992 crore deal